01 AI-Based Automation Transforming Bladder Volume Assessment The need for faster and more consistent bedside bladder assessment is encouraging the use of AI-enabled scanning functions in the Bladder Scanners Market. This shift is moving devices toward automated bladder detection, anatomical guidance, and volume calculation, which reduces operator dependence and supports more standardized measurements across care settings. Systems such as the EchoNous Kosmos Bladder illustrate this transition by using AI-assisted imaging to simplify bladder volume assessment at the point of care.
02 3D Bladder Imaging Gaining Importance The need for more accurate post-void residual and urinary-retention assessment is supporting a transition from basic volume estimation toward 3D bladder imaging. This development allows scanners to capture the bladder from multiple planes and generate more complete volumetric measurements, improving consistency in clinical decision-making. 3D bladder scanners are now widely used in urology, postoperative care, rehabilitation, and geriatric settings where repeated non-invasive volume checks help reduce unnecessary catheterization.
01 Higher Prevalence of Urinary Retention and Lower Urinary Tract Disorders and Greater Need to Reduce Unnecessary Urinary Catheterization Drive Market A higher prevalence of urinary retention, benign prostatic hyperplasia, neurogenic bladder, and other lower urinary tract disorders expands the patient pool requiring bladder-volume assessment. Greater diagnostic activity in urology, postoperative care, rehabilitation, and geriatric settings increases demand for non-invasive bladder scanners. Hospitals commonly use bladder scanning to measure post-void residual urine before deciding whether catheterization or further urological evaluation is necessary. A broader clinical need for repeated bladder assessment therefore supports device demand and encourages suppliers to expand portable scanner availability across care settings.A stronger focus on reducing avoidable catheter use increases the need for bladder scanners that help clinicians confirm urinary retention before catheter insertion. Lower catheter utilization can reduce patient discomfort and exposure to catheter-associated urinary tract infections, which makes non-invasive assessment more valuable in hospital protocols. Emergency departments, surgical wards, and nursing units increasingly use bladder scans to guide decisions on intermittent or indwelling catheterization. Wider adoption of catheter-reduction practices therefore strengthens demand for bladder scanners and supports broader procurement across acute and long-term care facilities.
01 High Cost of Advanced Bladder Scanning Systems and Limited Reimbursement and Budget Constraints High acquisition costs for bladder scanners with 3D imaging, automated volume measurement, and advanced software increase the capital burden on healthcare facilities. Smaller hospitals, clinics, and long-term care centers may delay purchases when budgets remain limited. This cost barrier restricts wider adoption and slows market penetration, particularly in price-sensitive healthcare systems.Limited reimbursement coverage reduces the financial incentive for healthcare providers to invest in dedicated bladder scanning equipment. Hospitals with restricted capital budgets may prioritize essential diagnostic and treatment devices over bladder scanners. This spending pressure delays procurement and replacement cycles, limiting broader market growth.
01 Development of Pediatric and Geriatric-Specific Bladder Scanning Solutions and Wider Adoption in Rehabilitation Centers and Postoperative Care Units Offers Growth Opportunities Medical device manufacturers, pediatric hospitals, geriatric care providers, and urology clinics can benefit from bladder scanners designed around age-specific anatomy and clinical needs. Specialized devices can open revenue through premium product lines, dedicated probes, software packages, and service contracts for pediatric and elderly care settings. Companies such as Verathon and Laborie already serve bladder volume assessment applications across hospital and urology environments.Rehabilitation centers, surgical hospitals, recovery units, and nursing facilities can benefit from routine bladder volume assessment during recovery and mobility-limited care. Broader use in these settings can create revenue through device placements, consumables, maintenance contracts, and recurring training or support services. Portable bladder scanner suppliers such as Verathon and dBMEDx are positioned to serve these point-of-care applications.
01 Blood Compatibility and Clotting Management Complicate Device Development and Supply Constraints for Critical Oxygenator Components Hinders Growth Blood contact with artificial lung membranes can trigger clot formation, while anticoagulation used to control this risk can contribute to bleeding complications. These competing risks make membrane design, clinical management, and product development more complex and can slow wider adoption of artificial lung systems. Recent ECMO evidence continues to identify bleeding and thrombosis among the most important complications of extracorporeal support.Artificial lung manufacturers depend on specialized oxygenators, membranes, pumps, sensors, and other medical-grade components that require strict quality control and reliable supply. Component shortages can limit production volumes, disrupt hospital availability, and make it difficult for companies to expand commercially. A real-life example is the U.S. FDA's June 2026 update extending shortages of extracorporeal-circulation oxygenator devices into the first quarter of 2027.
May 2026 Verathon expanded its urology portfolio with the U.S. launch of the CFlex™ single-use flexible cystoscope following FDA 510(k) clearance. The launch complements the company's BladderScan® portfolio and strengthens its presence in point-of-care urology solutions.
September 2025 Astrasono Technology received U.S. FDA 510(k) clearance for its A3Pro Bladder Scanner, expanding its portfolio of non-invasive ultrasound bladder volume measurement systems for hospitals, urology clinics, and point-of-care settings.
August 2025 Laborie showcased its expanded portfolio of urology diagnostic technologies, including bladder volume assessment solutions integrated with its urodynamic systems, strengthening its offering for comprehensive lower urinary tract diagnostics.
June 2025 Caresono introduced an upgraded generation of its portable wireless AI-assisted bladder scanner, featuring enhanced automatic bladder recognition, cloud-enabled data management, and improved point-of-care workflow for healthcare providers.